COMP <GO>
KOD vs IMVT // RETURN ON INVESTED CAPITAL (ROIC)
Kodiak Sciences Inc (NASDAQ) VS. Immunovant Inc. (NASDAQ) • 15-METRIC TALLY: KOD 6
— IMVT 4
■ METRIC PARITY
LAST: $98.89 (+1.30%) • MKT CAP: $6.14B
roic
-35.00%
LAST: $29.04 (+2.22%) • MKT CAP: $5.87B
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KOD VS. IMVT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KOD | IMVT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.16% | -6.65% | +4.49 | KOD | /fcf-yield <GO> |
| Operating Margin | -13.30% | -36.00% | +22.70 | KOD | /operating-margins <GO> |
| Net Profit Margin | -13.00% | -29.50% | +16.50 | KOD | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 9.90% | -8.80 | IMVT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 16.70 | 26.00 | -9.30 | IMVT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | IMVT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.0 | 36.4 | +26.60 | KOD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.98 | -0.08 | IMVT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.0x | 36.0x | -1.00 | KOD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.14B | $5.87B | $267.5M | KOD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KOD REV | IMVT REV | KOD GROSS % | IMVT GROSS % | KOD FCF | IMVT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $656.3M | $1.67B | — | — | -$136.5M | -$407.3M |
| FY 2024 | $523.2M | $1.37B | — | — | -$117.7M | -$376.6M |
| FY 2023 | $776.5M | $856.8M | — | — | -$154.2M | -$214.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KOD // BETA 0.90
IMVT // BETA 0.98